Searched for
MORTON GROVE
Wockhardt hires bankers for raising $300 million via dollar bondDue to a severe cash crunch, Wockhardt is facing a refinancing risk in FY19.04 Jul, 2018, 12.48 PM IST- Macquarie stays neutral on Wockhardt after arm gets USFDA warning letterThe brokerage firm said that while the warning letter will not impact its earnings estimates, it is certainly a setback to the company's on...02 Mar, 2017, 02.32 PM IST
- Wockhardt slips over 5% as arm receives warning letter from USFDAShares of the company opened at Rs 715 and touched a high and low of Rs 720 and Rs 701, respectively, in trade so far.02 Mar, 2017, 09.35 AM IST
- Fifteen stocks in focus on Thursday, 2 March 2017Banks including HDFC Bank, ICICI Bank and Axis Bank began charging a min amount of Rs 150 per transaction for cash deposits and withdrawals...02 Mar, 2017, 08.20 AM IST
- USFDA issues warning letter to Wockhardt's UK facilityThe significant violations included non-adherence to appropriate written procedures that are designed to prevent contamination of drugs.24 Nov, 2016, 01.30 AM IST
- Wockhardt surges 3% on USFDA nod to market pain-relieving drugShares of drug firm Wockhardt rose by nearly 3 per cent today as the company received approval from the US health regulator to market its O...22 Jun, 2015, 09.06 PM IST
- Wockhardt gets USFDA nod to market pain-relieving drugWockhardt is launching the product soon and will be amongst the few generic versions of this product in the market, it added.22 Jun, 2015, 01.55 PM IST
- Wockhardt slips nearly 4 per cent as Illinois unit comes under USFDA scannerWockhardt recouped some of the losses and was trading 2.8 per cent lower at Rs 578.50. It hit a low of Rs 573 and a high of Rs 589 in trade...04 Jun, 2014, 04.18 PM IST
- USFDA finds procedural lapses at Wockhardt's US facilityThe US Food and Drug Administration has found as many as 12 procedural lapses in drug maker Wockhardt's US facility in Illinois.03 Jun, 2014, 04.29 PM IST
- Wockhardt receives USFDA approval for Fluticasone nasal sprayWockhardt received final approval from the USFDA to market generic Fluticasone nasal spray, used for treating allergic nasal inflammation, ...10 Jan, 2012, 01.55 PM IST
- Wockhardt gains on Rhinitis drug launchShares of Wockhardt gained over 4% after the pharmaceutical major received final approval from the US FDA for marketing nasal spray of Flut...10 Jan, 2012, 01.01 PM IST
- Wockhardt climbs 5% on USFDA nodShares of drugmaker Wockhardt rose more than 5 per cent after its subsidiary in the US had won approval from FDA to market augmentin suspen...05 Dec, 2008, 10.52 AM IST
- Wockhardt Q1 FY 08 sales up 50 per cent at Rs 786 crorePharmaceutical and bio-tech major Wockhardt Ltd on Monday posted its consolidated sales for the first quarter ended March 31, 2008 at Rs 78...28 Apr, 2008, 04.17 PM IST
- Wockhardt buys Morton Grove for $38 mnDomestic drug maker Wockhardt said on Wednesday it acquired US-based speciality drugs company Morton Grove Pharmaceuticals, which has annua...25 Oct, 2007, 01.34 AM IST
- Wockhardt acquires US-based Morton GrovePharmaceutical major Wockhardt Ltd has acquired Morton Grove Pharmaceuticals, a liquid generic and specialty dermatology company in the US ...24 Oct, 2007, 11.46 AM IST
- Wockhardt buys Morton Grove of US; Q3 net profit down 35%Wockhardt Ltd has acquired Morton Grove Pharmaceuticals, a leading liquid generic and speciality dermatology company in the US having sales...24 Oct, 2007, 10.10 AM IST
- Wockhardt set to acquire US firm for $70 mnPharma major Wockhardt Ltd is in the final stages of acquiring US drug maker Morton Grove Pharmaceuticals Inc. Wockhardt plans to triple re...16 Oct, 2007, 12.00 AM IST
Load More
